Concepedia

Olena Barbash

OB

Statistics

Publications

36

Citations

4.8K

H-Index

30

Active since

2004

Affiliations

GlaxoSmithKline (United States)(Current)

University of Pennsylvania

The University of Texas MD Anderson Cancer Center

Cancer Research Institute

GlaxoSmithKline (United Kingdom)

Olena Barbash is an author at GlaxoSmithKline (United States) specializing in molecular oncology, molecular biology, and medicine.

Publications per year

2004–2024

36

Publications

36

A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models

Elayne Chan-Penebre, Kristy G. Kuplast, Christina R. Majer et al. · Nature Chemical Biology · 2015 · 546 citations

Medicine, Medicinal Chemistry, Pharmacology +8

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Paweł K. Mazur, Nicolas Reynoird, Purvesh Khatri et al. · Nature · 2014 · 409 citations · Full text

Medicine, Cancer Biology, Molecular Biology +14

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text

Medicine, Oncology, Pharmacology +7

Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex

Douglas I. Lin, Olena Barbash, Suresh Kumar et al. · Molecular Cell · 2006 · 344 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy et al. · Cancer Cell · 2019 · 279 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

1–5 of 36